A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis
2010 · Journal of Clinical Investigation · 352 citations
https://doi.org/10.1172/jci40535
C
Caterina Nardella
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
110
Papers
5.6K
Citations
23
h-index
27
i10-index
Caterina Nardella is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: PARP inhibition in cancer therapy & DNA Repair Mechanisms & Prostate Cancer Treatment and Research. The author has an h-index of 23, co-authored 94 publications.
ORCID: 0000-0002-1901-7916Papers by this author
worksA co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer
2013 · Nature Genetics · 143 citations
https://doi.org/10.1038/ng.2650
Zbtb7a suppresses prostate cancer through repression of a Sox9-dependent pathway for cellular senescence bypass and tumor invasion
2013 · Nature Genetics · 139 citations
https://doi.org/10.1038/ng.2654
Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity
2004 · Analytical Biochemistry · 20 citations
https://doi.org/10.1016/j.ab.2004.05.050
Supplementary Tables S1-S10 from Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25324611
Data from Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation
2024 · 0 citations
https://doi.org/10.1158/2159-8290.c.7100076.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat